Microchimerism, dendritic cell progenitors and transplantation tolerance

STEM CELLS

Volumn 13, Issue 6, 1995, Pages 622-639

  Thomson, Angus W ^a   Lu, Lina ^a   Murase, Noriko ^a   Demetris, Anthony J ^a   Rao, Abdul S ^a   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Bone marrow; Chimerism; Cytokines; Dendritic leukocytes; Liver; Organ transplants; Tolerance

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STREPTOZOCIN;

CHIMERA; CLONAL ANERGY; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION; REVIEW; STEM CELL; T LYMPHOCYTE ACTIVATION;

ANIMAL; DENDRITIC CELLS; HEART TRANSPLANTATION; HOST VS GRAFT REACTION; HUMAN; IMMUNE TOLERANCE; LIVER TRANSPLANTATION; MICE; STEM CELLS; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 0028838734     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.5530130607     Document Type: Article

References (119)

1. “Actively acquired tolerance” of foreign cells
2. Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance
3. Cell migration, chimerism, and graft acceptance
4. Cell migration and chimerism after whole organ tansplantation: the basis of graft acceptance
5. Systemic chimerism in human female recipients of male livers
6. Chimerism after liver transplantation for type IV glycogen storage disease and Type I Gaucher's disease
7. Chimerism and donor specific nonreactivity 27 to 29 years after kidney allotransplantation
8. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation
9. Allograft and xenograft acceptance under FK 506 and other immunosuppressive treatment
10. Transplantation milestones: viewed with one‐and two‐way paradigms of tolerance
11. Use of probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of donor bone marrow transplant recipients
12. Detection of residual host cells after bone marrow transplantation using non‐isotopic in situ hybridization and karyotype analysis
13. Explanation for loss of the HLA matching effect
14. Hematolymphoid cell trafficking, microchimerism, and GVHD reactions after liver, bone marrow, and heart transplantation
15. Murine liver allograft transplantation: tolerance and donor cell chimerism
16. Fine quantitation by competitive PCR of circulating donor cells in posttransplant chimeric recipients
17. Patterns of donor‐type microchimerism after heart transplantation
18. Evidence for the presence of hematopoietic stem cells in the adult liver
19. Propagation of dendritic cell progenitors from normal mouse liver using GM‐CSF and their maturational development in the presence of type‐1 collagen
20. In vitro propagation and homing of liver‐derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients
21. Propagation of cells expressing donor phenotype (MHC class 1, II and Y‐chromosome) from the bone marrow of murine liver allograft recipients in response to GM‐CSF in vitro
22. Growth of donor‐derived dendritic cells from the bone marrow of liver allograft recipients in response to granulocyte/macrophage colony‐stimulating factor
23. Identification of donor‐derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients
24. Identification of proliferating dendritic cell precursors in mouse blood
25. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony‐stimulating factor
26. A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM‐CSF, and their quantification using the mAb OX‐62
27. Variable chimerism, graft versus host disease, and tolerance after different kinds of cell and solid organ transplantation from Lewis to Brown‐Norway rats
28. Factors determining short‐and long‐term survival after orthotopic liver homotransplantation in the dog
29. Efforts to mitigate or prevent rejection
30. FK 506 suppression of heart and liver allograft rejection II: the induction of graft acceptance in rat
31. Liver transplantation in the pig: surgical approach
32. Orthotopic homotransplantation of the liver in the pig
33. Observations of orthotopic liver transplantation in the pig
34. Techniques for orthotopic liver transplantation in the rat and some studies of the immunologic responses to fully allogeneic liver grafts
35. Rejection of the multivisceral allograft in rats: a sequential analysts with comparison to isolated orthotopic small bowel and liver grafts
36. Reversal of transplantation immunity by liver grafting
37. Induction of immunological tolerance by porcine liver allografts
38. Hamster‐to‐rat liver xenografts protect extrahepatic organs from rejection
39. Primary vascularized allografts of hearts in mice: the role of H‐2D, H‐2K and non‐H‐2 antigens in rejection
40. Kidney transplants in mice. An analysis of the immune status of mice bearing long‐term G‐2 incompatible transplants
41. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus
42. The surface of dendritic cells in the mouse as studied with monoclonal antibodies
43. Split tolerance induced by orthotopic liver transplantation in mice
44. Cytokine mRNA profiles in murine orthotopic liver transplantation: graft rejection is associated with augmented Th1 cell function
45. Spontaneous acceptance of rat liver allografts is associated with an early downregulation of intragraft interleukin 4 messenger RNA expression
46. The dendritic cell system and its role in immunogenicity
47. Restoration of immunogenicity to passenger cell‐depleted kidney allografts by the addition of donor strain dendritic cells
48. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection
49. Migration patterns of dendritic leukocytes. Implications for transplantation
50. The initiation of immune responses and allograft rejection
51. Dendritic cells
52. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution
53. Identification of a novel cell type in the peripheral lymphoid organs of mice. II. Functional properties in vitro
54. Identification of a novel cell in peripheral lymphoid organs of mice. III. Functional properties in vivo
55. Studies of the role of the thymic environment in the induction of tolerance to MHC antigens
56. Does T‐cell tolerance require a dedicated antigen‐presenting cell?
57. Molecular events in the induction of a nonresponsive state in interleukin 2‐producing helper T‐lymphocyte clones
58. Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities
59. Peripheral tolerance mechanisms prevent the development of autoreactive T cells in chimeras grafts with two minor incompatible thymuses
60. Influence of dendritic cells on tumor growth
61. Contribution of dendritic cells to stimulation of the murine syngeneic mixed lymphocyte reaction
62. The syngeneic mixed leukocyte reaction in mice. II. The I region control of suppressor T cell activity induced in the syngeneic mixed lymphocyte reaction
63. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer
64. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells
65. + progenitors in human bone marrow
66. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL‐CFU) in human bone marrow and peripheral blood
67. + T cells
68. Understanding the dendritic cell lineage through a study of cytokine receptors
69. The LFA‐1 ligand ICAM‐1 provides an important costimulatory signal for T cell receptor‐mediated activation of resting T cells
70. Intercellular adhesion molecule‐2, a second counter‐receptor for CD11a/CD18 (leukocyte function‐associated antigen‐1), provides a costimulatory signal for T‐cell receptor‐initiated activation of human T cells
71. Complementary roles for CD2 and LFA‐1 adhesion pathways during T cell activation
72. CD28 delivers a costimulatory signal involved in antigen‐specific IL‐2 production by human T cells
73. Immobilized anti‐CD5 together with prolonged activation of protein kinase C induce interleukin 2‐dependent T cell growth: evidence for signal transduction through CD5
74. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid‐phase‐bound OKT3
75. Activation of human T4 cells by cross‐linking class IMHC molecules
76. Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction
77. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and a2–6 sialyltransferase, CD75, on B cells
78. Dendritic cells
79. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen‐presenting cells
80. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature
81. Differential function of dendritic cells isolated from blood and lymph nodes
82. Proliferating dendritic cell progenitors in human blood
83. Regulation of immunostimulatory function and costimulatory molecule (B7–1 and B7–2) expression on murine dendritic cells
84. Isolation and characterization of dendritic cells from mouse heart and kidney
85. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1
86. Isolation, immunophenotype and allostimulatory activity of murine liver dendritic cells
87. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function
88. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro
89. Immunologic properties of purified epidermal Langerhans cells: distinct requirements for stimulation of unprimed and sensitized T lymphocytes
90. Granulocyte/macrophage colony‐stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells
91. Granulocyte macrophage colony‐stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells
92. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells
93. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations
94. GM‐CSF and TNF‐α cooperate in the generation of dendritic Langerhans cells
95. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony‐stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
96. Stem cell factor augments tumor necrosis factor‐granulocyte‐macrophage colony‐stimulating factor‐mediated dendritic cell hematopoiesis
97. Demonstration and characterization of Ia‐positive dendritic cells in the interstitial connective tissues of rat heart and other tissues but not brain
98. Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues
99. Phenotype and histological distribution of interstitial dendritic cells in the rat pancreas, liver, heart and kidney
100. Characterization of interstitial dendritic cells in human liver
101. Generation of dendritic cells from mouse spleen cell cultures in response to GM‐CSF: immunophenotypic and functional analyses
102. Defective regional immunity in the respiratory tract of neonates is attributable to hyporesponsiveness of local dendritic cells to activation signals
103. In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen
104. In vitro differentiation of human monocytes. Monocytes cultured on glass are cytotoxic to tumor cells but monocytes cultured on collagen are not
105. 1 integrin
106. Migration and maturation of Langerhans cells in skin transplants and explants
107. Migration patterns of dendritic cells in the mouse. Homing to T cell‐dependent areas of spleen, and binding within marginal zone
108. Donor dendritic cells after liver and heart allotransplantation under short‐term immunosuppression
109. Indirect presentation of MHC antigens in transplantation
110. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart and pancreas islet transplantation
111. Proliferating dendritic cell progenitors in human blood
112. −) induce alloantigen‐specific hyporesponsiveness in murine T lymphocytes
113. Immature dendritic cells induce hyporesponsiveness to alloantigens in vitro and prolong mouse cardiac allograft survival
114. GM‐CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival
115. The role of passenger leukocytes in rejection and tolerance after solid organ transplantation: a potential explanation of a paradox